Researchers Identify Novel Immune Cells That May Worsen Asthma Jan. 15, 2025 — Researchers have made an important discovery in the field of asthma research, identifying a new population of ...

and how can someone with asthma avoid a bad asthma attack during the cold months? First, here's a brief overview of what people with asthma experience during an episode. According to the Asthma ...

There’s a chance people with asthma may have a bad reaction to nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. You can talk with your doctor about other options, including Tylenol.

The global allergy immunotherapy market size is calculated at USD 2.12 billion in 2025 and is expected to reach around USD 4.50 billion by 2034, growing at a CAGR of 8.73% for the forecasted ...

It can be difficult to tell asthma and COPD apart because both may include coughing, wheezing, and shortness of breath. Asthma is a risk factor for COPD and your chances of having both increase as ...

Results: History of ear infections was significantly related to the lifetime prevalence of diagnosed asthma (prevalence odds ratio [POR], 1.57; 95% confidence interval [CI], 1.05 to 2.36 ...

Although bronchial hyperresponsiveness to cholinergic agents is a main feature of asthma, the role of anticholinergic drugs in chronic asthma management has been largely underestimated.

Asthma is one of the major growth areas in therapeutics and many new drugs are currently in development. These drugs include improvements of existing classes of drugs, notably once-daily inhaled ...

Tanimilast is under clinical development by Chiesi Farmaceutici and currently in Phase II for Asthma. According to GlobalData, Phase II drugs for Asthma have a 27% phase transition success rate (PTSR) ...